Atlas Trials

A Study to Assess the Relative Bioavailability of Xisimin (Loratadine) Tablets Under Fasting and Fed Conditions in Healthy Participants Compared to Clarityne Tablets

Clinical trial NCT03151720 · COMPLETED

Trial details

NCT number
NCT03151720
Sponsor
Xian-Janssen Pharmaceutical Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2017-06-01
Primary completion
2017-07-08
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.